VC
COGT icon

Vivo Capital’s Cogent Biosciences COGT Stock Holding History

Vivo Capital’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.3M Sell
422,300
-1,976,693
-82% -$73M 1.35% 26
2025
Q4 		$85.2M Sell
2,398,993
-390,144
-14% -$11M 5.51% 4
2025
Q3 		$40.1M Buy
2,789,137
+1,666,666
+148% +$19.7M 3.22% 7
2025
Q2 		$8.06M Hold
1,122,471
– – 0.82% 27
2025
Q1 		$6.72M Hold
1,122,471
– – 0.89% 26
2024
Q4 		$8.76M Hold
1,122,471
– – 0.98% 24
2024
Q3 		$12.1M Sell
1,122,471
-1,122,470
-50% -$10.9M 1% 20
2024
Q2 		$18.9M Hold
2,244,941
– – 1.75% 14
2024
Q1 		$15.1M Hold
2,244,941
– – 1.19% 19
2023
Q4 		$13.2M Hold
2,244,941
– – 1.08% 18
2023
Q3 		$21.9M Hold
2,244,941
– – 2.4% 13
2023
Q2 		$26.6M Buy
2,244,941
+250,000
+13% +$2.87M 1.83% 12
2023
Q1 		$21.5M Hold
1,994,941
– – 1.49% 12
2022
Q4 		$23.1M Buy
1,994,941
+111,000
+6% +$1.38M 2.66% 13
2022
Q3 		$28.1M Sell
1,883,941
-37,000
-2% -$507K 3.1% 11
2022
Q2 		$17.3M Hold
1,920,941
– – 1.74% 12
2022
Q1 		$14.4M Hold
1,920,941
– – 0.99% 23
2021
Q4 		$16.5M Buy
1,920,941
+500,000
+35% +$4.35M 0.99% 25
2021
Q3 		$11.9M Buy
+1,420,941
New +$10.9M 0.54% 33

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vivo Capital's COGT Position: Q1 2026 in Review

Vivo Capital reduced its Cogent Biosciences (COGT) stake by 82% in Q1 2026, selling an estimated $73M and leaving 422,300 shares worth $16.3M. The position accounts for 1.35% of the portfolio, ranked #26.

Vivo Capital first reported a position in COGT in Q3 2021 and has held it in 19 quarters since. The position peaked at $85.2M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Vivo Capital held 422,300 shares of Cogent Biosciences worth $16.3M as of Q1 2026.
  • Vivo Capital sold 1,976,693 Cogent Biosciences shares in Q1 2026, an estimated $73M.
  • Cogent Biosciences made up 1.35% of Vivo Capital's portfolio in Q1 2026, its #26 holding.
  • Vivo Capital first reported a position in Cogent Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Vivo Capital's Cogent Biosciences position peaked at $85.2M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Vivo Capital's 13F filing for Q1 2026, filed 15 May 2026.